Corvus Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Corvus Pharmaceuticals Inc
TickerCRVS
CIK #0001626971
CUSIP221015100
SectorLife Sciences - Pharmaceutical Preparations
Address863 Mitten Road Suite 102, Burlingame, CA 94010
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Corvus Pharmaceuticals Inc 2015-09-25 75.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001626971] 10-K
[0001626971] 10-Q
[0001626971] 3
[0001626971] 4
[0001626971] 5
[0001626971] 8-K
[0001626971] D
[0001626971] SC 13D
[0001626971] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Sirenia Capital Management LP Corvus Pharmaceuticals Inc [2026-05-15] 0.0
Vanguard Group Inc Corvus Pharmaceuticals Inc [2026-01-30] 0.0
BlackRock Inc Corvus Pharmaceuticals Inc [2025-10-17] 0.0
Point72 Asset Management LP Corvus Pharmaceuticals Inc [2024-05-09] 0.9
Samlyn Capital LLC Corvus Pharmaceuticals Inc [2024-02-14] 5.1
CHI Advisors LLC Corvus Pharmaceuticals Inc [2023-02-13] 5.12
Integrated Core Strategies US LLC Corvus Pharmaceuticals Inc [2021-12-06] 4.5
Integrated Core Strategies US LLC Corvus Pharmaceuticals Inc [2021-10-22] 3.8
Venrock Healthcare Capital Partners II LP Corvus Pharmaceuticals Inc [2021-09-30] 8.1
Tang Capital Partners LP Corvus Pharmaceuticals Inc [2021-09-22] 8.8
EcoR1 Capital LLC Corvus Pharmaceuticals Inc [2021-05-11] 8.5
Price T Rowe Associates Inc /MD/ Corvus Pharmaceuticals Inc [2019-02-14] 6.7
Adams Street Partners LLC Corvus Pharmaceuticals Inc [2018-03-21] 15.5
Biotechnology Value Fund L P Corvus Pharmaceuticals Inc [2018-03-19] 3.2
Adams Street Partners LLC Corvus Pharmaceuticals Inc [2017-02-13] 13.0
FMR LLC Corvus Pharmaceuticals Inc [2016-08-10] 0.0
Miller Richard A MD Corvus Pharmaceuticals Inc [2016-04-08] 5.23
OrbiMed Advisors LLC Corvus Pharmaceuticals Inc [2016-04-01] 25.77
Novo A/S Corvus Pharmaceuticals Inc [2016-03-30] 15.5
Form 3/4/5 Filer 2011 - 2026
Corvus Pharmaceuticals Inc
Thompson Peter A
van den Broek Richard
Clark Ian T
Moore David Scott
Grais Linda
Miller Richard A MD
Chan Andrew C
Jones William Benton
Arcara Jeffrey
Lea LEIV
OrbiMed Advisors LLC
OrbiMed Capital GP V LLC
Morrison Scott W
Gould Terry P
Mitchell Edith P
Adams Street Partners LLC
EcoR1 Capital LLC
Mobasher Mehrdad
Novo Holdings A/S
Krognes Steve E
Verner Erik J
Buggy Joseph J
Hunt Daniel W
Isaly Samuel D
Coloma Jason V
Moldt Peter
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Thompson Peter A
Common Stock
2026-01-28 Option exercise 15,000 $2.49 37,350
Thompson Peter A
Common Stock
2026-01-28 Option exercise 15,000 $9.70 145,500
Thompson Peter A
Common Stock
2026-01-28 Option exercise 30,000 $15.00 450,000
Thompson Peter A
Common Stock
2026-01-28 Option exercise 15,000 $3.61 54,150
Thompson Peter A
Common Stock
2026-01-28 Option exercise 15,000 $2.00 30,000
Thompson Peter A
Common Stock
2026-01-28 Option exercise 15,000 $3.27 49,050
Thompson Peter A
Common Stock
2026-01-28 Option exercise 15,000 $2.12 31,800
Thompson Peter A
Common Stock
2026-01-28 Option exercise 15,000 $2.60 39,000
Thompson Peter A
Common Stock
2026-01-28 Option exercise 15,000 $0.99 14,850
Thompson Peter A
Common Stock
2026-01-28 Option exercise 15,000 $0.97 14,550
Thompson Peter A
Common Stock
2026-01-28 Option exercise 15,000 $1.64 24,600
Thompson Peter A
Common Stock
2026-01-28 Option exercise 15,000 $2.74 41,100
Thompson Peter A
Stock Option (Right to Buy) · derivative
2026-01-28 Option exercise 15,000 $0.00
Thompson Peter A
Stock Option (Right to Buy) · derivative
2026-01-28 Option exercise 15,000 $0.00
Thompson Peter A
Stock Option (Right to Buy) · derivative
2026-01-28 Option exercise 15,000 $0.00
Thompson Peter A
Stock Option (Right to Buy) · derivative
2026-01-28 Option exercise 15,000 $0.00
Thompson Peter A
Stock Option (Right to Buy) · derivative
2026-01-28 Option exercise 15,000 $0.00
Thompson Peter A
Stock Option (Right to Buy) · derivative
2026-01-28 Option exercise 15,000 $0.00
Thompson Peter A
Stock Option (Right to Buy) · derivative
2026-01-28 Option exercise 30,000 $0.00
Thompson Peter A
Stock Option (Right to Buy) · derivative
2026-01-28 Option exercise 15,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 165 68,969,716
2025-12-31 125 47,853,573
2025-09-30 105 42,070,676
2025-06-30 95 42,206,232
2025-03-31 93 37,912,477
2024-12-31 91 41,515,503
2024-09-30 66 31,219,021
2024-06-30 48 27,653,561
2024-03-31 49 18,563,413
2023-12-31 49 19,542,871
2023-09-30 53 19,304,936
2023-06-30 55 19,662,720
Form 13F Holdings
Firm Period DFND Voting Shares
TEMA ETFS LLC [2026-06-30] SOLE 136,276 136,276
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 43,769 43,769
Avity Investment Management Inc [2026-06-30] SOLE 35,450 37,150
Curated Wealth Partners LLC [2026-06-30] OTR 0 15,000
Sowell Financial Services LLC [2026-06-30] SOLE 14,975 14,975
Gamma Investing LLC [2026-06-30] DFND 679 679
Farther Finance Advisors LLC [2026-06-30] SOLE 0 426
Physician Wealth Advisors Inc [2026-06-30] SOLE 0 177
Eastern Bank [2026-06-30] DFND 92 92
Versant Capital Management Inc [2026-06-30] SOLE 28 28
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com